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Background: Growing evidence supports the role of post-contrast myocardial T1 time determination with cardiac magnetic resonance (CMR) T1-
mapping in the evaluation of cardiac amyloidosis (CA). Our aim was to evaluate whether post-contrast myocardial T1 reduction can be used as a 
surrogate of the extent of myocardial amyloid deposition as quantified histologically.
Methods: Consecutive patients referred for 1.5 Tesla CMR for clinically suspected CA who additionally underwent cardiac biopsy were 
retrospectively identified. Myocardial amyloid was quantified from tissue sections using the Image Pro Plus software by determining the ratio of 
Congo red positive extracellular proteinaceous deposition to the total sample area. Myocardial and endocardial T1 times as well as the respective 
ratios with blood and skeletal muscle were determined on Look-Locker sequences approximately 10 minutes after the administration of 0.02 mmol/
Kg of Gd-DTPA using dedicated software.
results: 17 patients (15 males [88.2%], age 64±15 years) were included, from which 11 (64.7%) had a final diagnosis of CA. The median amyloid 
deposition ratio in cardiac biopsies was 0.11 [IQR 0-0.25]. The correlations of amyloid deposition in cardiac biopsy with the T1 mapping parameters 
are shown in the Table:
Correlation (r) P value
Myocardial T1 -0.546 0.023
Endocardial T1 -0.464 0.061
Myocardium/Blood T1 -0.496 0.043
Myocardium/Skeletal muscle T1 -0.543 0.024
Endocardium/Blood T1 -0.529 0.029
Endocardium/Skeletal muscle T1 -0.474 0.055
conclusion: Reduction in myocardial T1 times correlates with the extent of amyloid deposition in the heart as validated histologically. T1 mapping 
offers the potentially to noninvasively estimate myocardial amyloid burden.
